Dare Bioscience Inc (NAS:DARE)
$ 3.18 -0.01 (-0.31%) Market Cap: 27.75 Mil Enterprise Value: 21.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Dare Bioscience Inc at Stifel Healthcare Conference Transcript

Nov 15, 2022 / 02:10PM GMT
Release Date Price: $11.4 (-3.05%)
Unidentified Participant

Hi. Good morning. And welcome to the Daré Bioscience's presentation. It's our pleasure to have CEO Sabrina Johnson here with us, who's leading one of the more innovative women's health company. And hopefully you've done it right this time; you've got the right formula.

So I'm just going to leave this to you to describe that.

Sabrina Johnson;Bioscience
DarÃ;Inc. - President and CEO

© -

Thank you for the kind introduction. And thank you for those of you listening in today, excited to always get an overview on what we're doing at Daré. So as the presentation does contain forward-looking statements, I do encourage you to look at our SEC filings for a full overview of the risks if it sits with Daré.

So we are focused solely in squaring in women's health, and I'll get into today's the why. But before I get into the why, I'll give you a little bit of sense of the how. And then all about it is that our model is a little bit different.

And our how inches in how we innovate in women's health is we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot